Is depression associated with increased oxidative stress? A systematic review and meta-analysis

Psychoneuroendocrinology

Volumn 51, Issue , 2015, Pages 164-175

  Black, Catherine N ^a,c   Bot, Mariska ^a,c   Scheffer, Peter G ^a   Cuijpers, Pim ^b,c   Penninx, Brenda W J H ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

8 Hydroxy 2' deoxyguanosine (8 OHdG); Bipolar disorder; Depression; F2 isoprostanes; Major depressive disorder; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ISOPROSTANE DERIVATIVE; 8-OXO-7-HYDRODEOXYGUANOSINE; BIOLOGICAL MARKER; DEOXYGUANOSINE;

ARTICLE; BIPOLAR DISORDER; CHROMATOGRAPHY; DEPRESSION; HUMAN; IMMUNOASSAY; MAJOR DEPRESSION; MASS SPECTROMETRY; OXIDATIVE STRESS; PLASMA; SERUM; SYSTEMATIC REVIEW; URINE; ANALOGS AND DERIVATIVES; META ANALYSIS; METABOLISM; PHYSIOLOGY;

BIOLOGICAL MARKERS; BIOMARKERS; BIPOLAR DISORDER; DEOXYGUANOSINE; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; F2-ISOPROSTANES; HUMANS; OXIDATIVE STRESS;

EID: 84920572199     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.09.025     Document Type: Article

References (78)

1. Abu-Omar K., Rutten A., Lehtinen V. Mental health and physical activity in the European Union. Soz. Praventivmed. 2004, 49:301-309.
2. Andreazza A.C., Kauer-Sant'anna M., Frey B.N., Bond D.J., Kapczinski F., Young L.T., Yatham L.N. Oxidative stress markers in bipolar disorder: a meta-analysis. J. Affect. Disord. 2008, 111:135-144.
3. Andreazza A.C., Frey B.N., Erdtmann B., Salvador M., Rombaldi F., Santin A., Goncalves C.A., Kapczinski F. DNA damage in bipolar disorder. Psychiatry Res. 2007, 153:27-32.
4. Andreazza A.C., Kapczinski F., Kauer-Sant'anna M., Walz J.C., Bond D.J., Goncalves C.A., Young L.T., Yatham L.N. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J. Psychiatry Neurosci. 2009, 34:263-271.
5. Barnes D.E., Alexopoulos G.S., Lopez O.L., Williamson J.D., Yaffe K. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch. Gen. Psychiatry 2006, 63:273-279.
6. Behr G.A., Moreira J.C.F., Frey B.N. Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxid. Med. Cell Longev. 2012, 2012:609421.
7. Bijl R.V., Ravelli A. Psychiatric morbidity, service use, and need for care in the general population: results of The Netherlands Mental Health Survey and Incidence Study. Am. J. Public Health 2000, 90:602-607.
8. Ceprnja M., Derek L., Unic A., Blazev M., Fistonic M., Kozaric-Kovacic D., Franic M., Romic Z. Oxidative stress markers in patients with post-traumatic stress disorder. Coll. Antropol. 2011, 35:1155-1160.
9. Ceylan D., Tuna G., Kirkali G., Dizdaronulllu M., Tunca Z., Yesilyurt S., Ozerdem A. DNA damage in bipolar disorder: a quantitative assessment by using gas chromatography-isotope dilution mass spectrometry (GC-MS) null. Bipolar Disord. 2012, 14(Suppl. 1):66.
10. Ceylan D., Tuna G., Kirkali G., Tunca Z., Dizdaronulllu M., Can G., Arat E., Ozerdem A. Increased oxidative base damage to DNA in bipolar disorder: a cross-sectional case control study. Bipolar Disord. 2013, 15(1):55.
11. Che Y., Wang J.F., Shao L., Young T. Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J. Psychiatry Neurosci. 2010, 35:296-302.
12. Chida Y., Hamer M., Wardle J., Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival?. Nat. Clin. Pract. Oncol. 2008, 5:466-475.
13. Chung C.P., Schmidt D., Stein C.M., Morrow J.D., Salomon R.M. Increased oxidative stress in patients with depression and its relationship to treatment. Psychiatry Res. 2013, 206:213-216.
14. Chung C.P., Titova D., Oeser A., Randels M., Avalos I., Milne G.L., Morrow J.D., Stein C.M. Oxidative stress in fibromyalgia and its relationship to symptoms. Clin. Rheumatol. 2009, 28:435-438.
15. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Erlbaum, Hillsdale, NJ.
16. Cuijpers P., Vogelzangs N., Twisk J., Kleiboer A., Li J., Penninx B.W. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am. J. Psychiatry 2014, 171:453-462.
17. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A. Biomarkers of oxidative damage in human disease. Clin. Chem. 2006, 52:601-623.
18. de Sousa R.T., Zarate C.A.J., Zanetti M.V., Costa A.C., Talib L.L., Gattaz W.F., hado-Vieira R. Oxidative stress in early stage bipolar disorder and the association with response to lithium. J. Psychiatr. Res. 2014, 50:36-41.
19. Dimopoulos N., Piperi C., Psarra V., Lea R.W., Kalofoutis A. Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression. Psychiatry Res. 2008, 161:59-66.
20. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
21. Forlenza M.J., Miller G.E. Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression. Psychosom. Med. 2006, 68:1-7.
22. Freund-Levi Y., Cederholm T., Basu S. Oxidative stress and cox-mediated inflammation in patients with Alzheimer's disease and effects of N-3 fatty acid supplementation the omegAD study. Clin. Nutr. 2011, 6(Suppl. 1):9.
23. Gawryluk J.W., Wang J.F., Andreazza A.C., Shao L., Young L.T. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int. J. Neuropsychopharmacol. 2011, 14:123-130.
24. Glassman A.H., Helzer J.E., Covey L.S., Cottler L.B., Stetner F., Tipp J.E., Johnson J. Smoking, smoking cessation, and major depression. J. Am. Med. Assoc. 1990, 264:1546-1549.
25. Grande I., Magalhaes P.V., Kunz M., Vieta E., Kapczinski F. Mediators of allostasis and systemic toxicity in bipolar disorder. Physiol. Behav. 2012, 106:46-50.
26. Gubert C., Stertz L., Pfaffenseller B., Panizzutti B.S., Rezin G.T., Massuda R., Streck E.L., Gama C.S., Kapczinski F., Kunz M. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. J. Psychiatr. Res. 2013, 47:1396-1402.
27. Hayden J.A., Cote P., Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann. Intern. Med. 2006, 144:427-437.
28. Higgins J.P.T., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. Br. Med. J. 2003, 327:557-560.
29. Ho E., Karimi Galougahi K., Liu C., Bhindi R., Figtree G. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol. 2013, 1:483-491.
30. Huzayyin A.A., Andreazza A.C., Turecki G., Cruceanu C., Rouleau G.A., Alda M., Young L.T. Decreased global methylation in patients with bipolar disorder who respond to lithium. Int. J. Neuropsychopharmacol. 2014, 17:561-569.
31. Iida T., Chikamura C., Inoue K., Ito Y., Ishikawa H., Teradaira R., Ono Y. Association of STAI and SDS scores with 8-hydroxydeoxyguanosine and serotonin levels in young women with depressive symptoms. J. Neuropsychiatry Clin. Neurosci. 2011, 23:E10.
32. Ioannidis J.P.A., Patsopoulos N.A., Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. Br. Med. J. 2007, 335:914-916.
33. Irie M., Asami S., Nagata S., Ikeda M., Miyata M., Kasai H. Psychosocial factors as a potential trigger of oxidative DNA damage in human leukocytes. Jpn. J. Cancer Res. 2001, 92:367-376.
34. Irie M., Asami S., Ikeda M., Kasai H. Depressive state relates to female oxidative DNA damage via neutrophil activation. Biochem. Biophys. Res. Commun. 2003, 311:1014-1018.
35. Irie M., Asami S., Nagata S., Miyata M., Kasai H. Psychological mediation of a type of oxidative DNA damage, 8-hydroxydeoxyguanosine, in peripheral blood leukocytes of non-smoking and non-drinking workers. Psychother. Psychosom. 2002, 71:90-96.
36. Irie M., Miyata M., Kasai H. Depression and possible cancer risk due to oxidative DNA damage. J. Psychiatr. Res. 2005, 39:553-560.
37. Janicki-Deverts D., Cohen S., Matthews K.A., Gross M.D., Jacobs D.R.J. Socioeconomic status, antioxidant micronutrients, and correlates of oxidative damage: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Psychosom. Med. 2009, 71:541-548.
38. Joergensen A., Broedbaek K., Weimann A., Semba R.D., Ferrucci L., Joergensen M.B., Poulsen H.E. Association between urinary excretion of cortisol and markers of oxidatively damaged DNA and RNA in humans. PLoS ONE 2011, 6:e20795. 10.1371/journal.pone.0020795.
39. Jorgensen A., Krogh J., Miskowiak K., Bolwig T.G., Kessing L.V., Fink-Jensen A., Nordentoft M., Henriksen T., Weimann A., Poulsen H.E., Jorgensen M.B. Systemic oxidatively generated DNA/RNA damage in clinical depression: associations to symptom severity and response to electroconvulsive therapy. J. Affect. Disord. 2013, 149:355-362.
40. Kapczinski F., Dal-Pizzol F., Teixeira A.L., Magalhaes P.V.S., Kauer-Sant'anna M., Klamt F., Moreira J.C., de Bittencourt Pasquali M.A., Fries G.R., Quevedo J., Gama C.S., Post R. Peripheral biomarkers and illness activity in bipolar disorder. J. Psychiatr. Res. 2011, 45:156-161.
41. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J. Am. Med. Assoc. 2003, 289:3095-3105.
42. Khairova R., Pawar R., Salvadore G., Juruena M.F., de Sousa R.T., Soeiro-de-Souza M.G., Salvador M., Zarate C.A., Gattaz W.F., hado-Vieira R. Effects of lithium on oxidative stress parameters in healthy subjects. Mol. Med. Rep. 2012, 5:680-682.
43. Kupper N., Gidron Y., Winter J., Denollet J. Association between type D personality, depression, and oxidative stress in patients with chronic heart failure. Psychosom. Med. 2009, 71:973-980.
44. Luppino F.S., de Wit L.M., Bouvy P.F., Stijnen T., Cuijpers P., Penninx B.W.J.H., Zitman F.G. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry 2010, 67:220-229.
45. Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:676-692.
46. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuroendocrinol. Lett. 2009, 30:715-722.
47. Magalhaes P.V.S., Jansen K., Pinheiro R.T., Colpo G.D., da Motta L.L., Klamt F., da Silva R.A., Kapczinski F. Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. Int. J. Neuropsychopharmacol. 2012, 15:1043-1050.
48. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 2003, 17:24-38.
49. Matsumoto Y., Ogawa Y., Yoshida R., Shimamori A., Kasai H., Ohta H. The stability of the oxidative stress marker, urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG), when stored at room temperature. J. Occup. Health 2008, 50:366-372.
50. McEwen B.S., Wingfield J.C. The concept of allostasis in biology and biomedicine. Horm. Behav. 2003, 43:2-15.
51. Meagher E.A., FitzGerald G.A. Indices of lipid peroxidation in vivo: strengths and limitations. Free Rad. Biol. Med. 2000, 28:1745-1750.
52. Mezuk B., Eaton W.W., Albrecht S., Golden S.H. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008, 31:2383-2390.
53. Michel T.M., Pulschen D., Thome J. The role of oxidative stress in depressive disorders. Curr. Pharm. Des. 2012, 18:5890-5899.
54. Milaneschi Y., Cesari M., Simonsick E.M., Vogelzangs N., Kanaya A.M., Yaffe K., Patrignani P., Metti A., Kritchevsky S.B., Pahor M., Ferrucci L., Penninx B.W.J.H. Lipid peroxidation and depressed mood in community-dwelling older men and women. PLoS ONE 2013, 8:e65406.
55. Nicholson A., Kuper H., Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur. Heart J. 2006, 27:2763-2774.
56. Niki E. Biomarkers of lipid peroxidation in clinical material. Biochim. Biophys. Acta 2014, 1840:809-817.
57. Palta P., Samuel L.J., Miller E.R., Szanton S.L. Depression and oxidative stress: results from a meta-analysis of observational studies. Psychosom. Med. 2014, 76:12-19.
58. Pandya C.D., Howell K.R., Pillai A. Antioxidants as potential therapeutics for neuropsychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 46:214-223.
59. Penninx B.W.J.H., Milaneschi Y., Lamers F., Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med. 2013, 11:129.
60. Pomara N., Bruno D., Sarreal A.S., Hernando R.T., Nierenberg J., Petkova E., Sidtis J.J., Wisniewski T.M., Mehta P.D., Pratico D., Zetterberg H., Blennow K. Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. Am. J. Psychiatry 2012, 169:523-530.
61. Rawdin B.J., Mellon S.H., Dhabhar F.S., Epel E.S., Puterman E., Su Y., Burke H.M., Reus V.I., Rosser R., Hamilton S.P., Nelson J.C., Wolkowitz O.M. Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav. Immun. 2013, 31:143-152.
62. Segal B.M., Thomas W., Zhu X., Diebes A., McElvain G., Baechler E., Gross M. Oxidative stress and fatigue in systemic lupus erythematosus. Lupus 2012, 21:984-992.
63. Soeiro-de-Souza M.G., Andreazza A.C., Carvalho A.F., hado-Vieira R., Young L.T., Moreno R.A. Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder. Int. J. Neuropsychopharmacol. 2013, 16:1505-1512.
64. Sterne J.A., Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J. Clin. Epidemiol. 2001, 54:1046-1055.
65. Sullivan L.E., Fiellin D.A., O'Connor P.G. The prevalence and impact of alcohol problems in major depression: a systematic review. Am. J. Med. 2005, 118:330-341.
66. Valavanidis A., Vlachogianni T., Fiotakis C. 8-Hydroxy-2'-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health C: Environ. Carcinog. Ecotoxicol. Rev. 2009, 27:120-139.
67. Valko M., Leibfritz D., Moncol J., Cronin M.T.D., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
68. Verhoeven J., Révész D., Epel E., Lin J., Wolkowitz O., Penninx B. Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study. Mol. Psychiatry 2013, 10.1038/mp.2013.151.
69. Vos T., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M., Shibuya K., Salomon J.A., Abdalla S., Aboyans V., Abraham J., Ackerman I., Aggarwal R., Ahn S.Y., Ali M.K., Alvarado M., Anderson H.R., Anderson L.M., Andrews K.G., Atkinson C., Baddour L.M., Bahalim A.N., Barker-Collo S., Barrero L.H., Bartels D.H., Basanez M.G., Baxter A., Bell M.L., Benjamin E.J., Bennett D., Bernabe E., Bhalla K., Bhandari B., Bikbov B., Bin Abdulhak A., Birbeck G., Black J.A., Blencowe H., Blore J.D., Blyth F., Bolliger I., Bonaventure A., Boufous S., Bourne R., Boussinesq M., Braithwaite T., Brayne C., Bridgett L., Brooker S., Brooks P., Brugha T.S., Bryan-Hancock C., Bucello C., Buchbinder R., Buckle G., Budke C.M., Burch M., Burney P., Burstein R., Calabria B., Campbell B., Canter C.E., Carabin H., Carapetis J., Carmona L., Cella C., Charlson F., Chen H., Cheng A.T.-A., Chou D., Chugh S.S., Coffeng L.E., Colan S.D., Colquhoun S., Colson K.E., Condon J., Connor M.D., Cooper L.T., Corriere M., Cortinovis M., de Vaccaro K.C., Couser W., Cowie B.C., Criqui M.H., Cross M., Dabhadkar K.C., Dahiya M., Dahodwala N., msere-Derry J., Danaei G., Davis A., De Leo D., Degenhardt L., Dellavalle R., Delossantos A., Denenberg J., Derrett S., Des Jarlais D.C., Dharmaratne S.D., Dherani M., az-Torne C., Dolk H., Dorsey E.R., Driscoll T., Duber H., Ebel B., Edmond K., Elbaz A., Ali S.E., Erskine H., Erwin P.J., Espindola P., Ewoigbokhan S.E., Farzadfar F., Feigin V., Felson D.T., Ferrari A., Ferri C.P., Fevre E.M., Finucane M.M., Flaxman S., Flood L., Foreman K., Forouzanfar M.H., Fowkes F.G., Franklin R., Fransen M., Freeman M.K., Gabbe B.J., Gabriel S.E., Gakidou E., Ganatra H.A., Garcia B., Gaspari F., Gillum R.F., Gmel G., Gosselin R., Grainger R., Groeger J., Guillemin F., Gunnell D., Gupta R., Haagsma J., Hagan H., Halasa Y.A., Hall W., Haring D., Haro J.M., Harrison J.E., Havmoeller R., Hay R.J., Higashi H., Hill C., Hoen B., Hoffman H., Hotez P.J., Hoy D., Huang J.J., Ibeanusi S.E., Jacobsen K.H., James S.L., Jarvis D., Jasrasaria R., Jayaraman S., Johns N., Jonas J.B., Karthikeyan G., Kassebaum N., Kawakami N., Keren A., Khoo J.P., King C.H., Knowlton L.M., Kobusingye O., Koranteng A., Krishnamurthi R., Lalloo R., Laslett L.L., Lathlean T., Leasher J.L., Lee Y.Y., Leigh J., Lim S.S., Limb E., Lin J.K., Lipnick M., Lipshultz S.E., Liu W., Loane M., Ohno S.L., Lyons R., Ma J., Mabweijano J., MacIntyre M.F., Malekzadeh R., Mallinger L., Manivannan S., Marcenes W., March L., Margolis D.J., Marks G.B., Marks R., Matsumori A., Matzopoulos R., Mayosi B.M., McAnulty J.H., McDermott M.M., McGill N., McGrath J., Medina-Mora M.E., Meltzer M., Mensah G.A., Merriman T.R., Meyer A.C., Miglioli V., Miller M., Miller T.R., Mitchell P.B., Mocumbi A.O., Moffitt T.E., Mokdad A.A., Monasta L., Montico M., Moradi-Lakeh M., Moran A., Morawska L., Mori R., Murdoch M.E., Mwaniki M.K., Naidoo K., Nair M.N., Naldi L., Narayan K.M.V., Nelson P.K., Nelson R.G., Nevitt M.C., Newton C.R., Nolte S., Norman P., Norman R., O'Donnell M., O'Hanlon S., Olives C., Omer S.B., Ortblad K., Osborne R., Ozgediz D., Page A., Pahari B., Pandian J.D., Rivero A.P., Patten S.B., Pearce N., Padilla R.P., Perez-Ruiz F. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2163-2196.
70. Wang J.F., Shao L., Sun X., Young L.T. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 2009, 11:523-529.
71. Wei Y.C., Zhou F.L., He D.L., Bai J.R., Ding H., Wang X.Y., Nan K.J. Oxidative stress in depressive patients with gastric adenocarcinoma. Int. J. Neuropsychopharmacol. 2009, 12:1089-1096.
72. Wei Y.C., Zhou F.L., He D.L., Bai J.R., Hui L.y., Wang X.Y., Nan K.J. The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma. J. Psychosom. Res. 2009, 66:259-266.
73. Wolkowitz O.M., Mellon S.H., Epel E.S., Lin J., Dhabhar F.S., Su Y., Reus V.I., Rosser R., Burke H.M., Kupferman E., Compagnone M., Nelson J.C., Blackburn E.H. Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress - preliminary findings. PLoS ONE 2011, 6:e17837.
74. Wolkowitz O.M., Reus V.I., Mellon S.H. Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin. Neurosci. 2011, 13:25-39.
75. Wu I.C., Shiesh S.C., Kuo P.H., Lin X.Z. High oxidative stress is correlated with frailty in elderly Chinese. J. Am. Geriatr. Soc. 2009, 57:1666-1671.
76. Yager S., Forlenza M.J., Miller G.E. Depression and oxidative damage to lipids. Psychoneuroendocrinology 2010, 35:1356-1362.
77. Yi S., Nanri A., Matsushita Y., Kasai H., Kawai K., Mizoue T. Depressive symptoms and oxidative DNA damage in Japanese municipal employees. Psychiatry Res. 2012, 200:318-322.
78. Yoshida R., Ogawa Y., Kasai H. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine values measured by an ELISA correlated well with measurements by high-performance liquid chromatography with electrochemical detection. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1076-1081.